Matches in Nanopublications for { ?s ?p "[MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP268058.RALA9xXmLsFQq87UvxMKnwy9RnUehc0KbzZ3E3QeGWnWM130_assertion description "[MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP268058.RALA9xXmLsFQq87UvxMKnwy9RnUehc0KbzZ3E3QeGWnWM130_provenance.
- assertion description "[MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP915961.RARxBlRntABXtf8KNpyGbW0V0_qdWo2UsO6ImtOSiaTH0130_assertion description "[MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915961.RARxBlRntABXtf8KNpyGbW0V0_qdWo2UsO6ImtOSiaTH0130_provenance.
- NP994056.RAlkslqPHNLDSOkBqevC4QPioZXfOqn27ixcD0euz3G9o130_assertion description "[MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP994056.RAlkslqPHNLDSOkBqevC4QPioZXfOqn27ixcD0euz3G9o130_provenance.
- NP915963.RAhW2luvJMF0rtDQUoBQMC5AXoYBrKKIfUD8FXs84mClw130_assertion description "[MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP915963.RAhW2luvJMF0rtDQUoBQMC5AXoYBrKKIfUD8FXs84mClw130_provenance.